Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia by Eric L. Sievers, Beverly J. Lange, Todd A. Alonzo, Robert B. Gerbing, Irwin D. Bernstein, Franklin O. Smith, Robert J. Arceci, William G. Woods, and Michael R. Loken Blood Volume 101(9):3398-3406 May 1, 2003 ©2003 by American Society of Hematology Design of Children's Cancer Group AML Treatment Study 2961.Marrow samples were aspirated fresh and submitted to the AML Reference Laboratory at diagnosis, and at the end of induction, consolidation, and intensification therapies. “DCTER*” refers to dexameth... Eric L. Sievers et al. Blood 2003;101:3398-3406 ©2003 by American Society of Hematology Survival comparing outcomes between patients with any occult leukemia detectable by flow cytometry at the end of consolidation therapy censoring for allogeneic transplant.Overall survival 3 years after the end of consolidation was 41% ± 26% versus 69% ± 10%... Eric L. Sievers et al. Blood 2003;101:3398-3406 ©2003 by American Society of Hematology